RAFFA WEALTH MANAGEMENT, LLC’s ImmunityBio IBRX Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35	Buy	+4	New	+$30	﹤0.01%	1543

Other funds holding IBRX

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Sheets Smith Wealth Management Winston-Salem, North Carolina $1B AUM 29.77% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

MFG Wealth Management Indianapolis, Indiana $140M AUM 44.72% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Davidson Kahn Capital Management Sherman Oaks, California $233M AUM 19.14% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's IBRX Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC opened a new position in ImmunityBio (IBRX) in Q2 2026: 4 shares worth $35. The stake represents ﹤0.01% of the portfolio and ranks #1543 among its holdings.

115 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

RAFFA WEALTH MANAGEMENT, LLC held 4 shares of ImmunityBio worth $35 as of Q2 2026.
ImmunityBio was a new RAFFA WEALTH MANAGEMENT, LLC position in Q2 2026.
ImmunityBio made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #1543 holding.
115 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.